BACKGROUND: Exhaled nitric oxide (eNO) may serve as a non-invasive marker of airway inflammation but its relationship with other commonly used measures has not been evaluated. METHODS: Levels of eNO in a sample of 450 children aged 7-12 years out of a total sample of 2504 school children living in different urban areas near motorways were determined. The aim of this cross-sectional study was to explore the relationship between eNO, impairment of lung function (PEF, FVC, FEV(1) and MMEF), bronchial hyperresponsiveness (BHR), and blood eosinophilia in children with and without atopy as assessed by skin prick testing. RESULTS: Regression analysis showed that wheezing and nasal discharge and conjunctivitis that had occurred during the previous 12 months were positively associated with eNO levels in atopic children (relative increase of 1.48 and 1.41, respectively; p<0.05) but not in non-atopic children. Similarly, BHR and the number of blood eosinophils per ml were positively associated with eNO levels in atopic children (relative increase of 1.55 and 2.29, respectively; p<0.05) but not in non-atopic children. The lung function indices PEF, FVC, FEV(1) and MMEF were not associated with eNO levels. CONCLUSIONS: In addition to conventional lung function tests and symptom questionnaires, eNO is a suitable measure of airway inflammation and its application may reinforce the power of epidemiological surveys on respiratory health.
BACKGROUND: Exhaled nitric oxide (eNO) may serve as a non-invasive marker of airway inflammation but its relationship with other commonly used measures has not been evaluated. METHODS: Levels of eNO in a sample of 450 children aged 7-12 years out of a total sample of 2504 school children living in different urban areas near motorways were determined. The aim of this cross-sectional study was to explore the relationship between eNO, impairment of lung function (PEF, FVC, FEV(1) and MMEF), bronchial hyperresponsiveness (BHR), and blood eosinophilia in children with and without atopy as assessed by skin prick testing. RESULTS: Regression analysis showed that wheezing and nasal discharge and conjunctivitis that had occurred during the previous 12 months were positively associated with eNO levels in atopic children (relative increase of 1.48 and 1.41, respectively; p<0.05) but not in non-atopic children. Similarly, BHR and the number of blood eosinophils per ml were positively associated with eNO levels in atopic children (relative increase of 1.55 and 2.29, respectively; p<0.05) but not in non-atopic children. The lung function indices PEF, FVC, FEV(1) and MMEF were not associated with eNO levels. CONCLUSIONS: In addition to conventional lung function tests and symptom questionnaires, eNO is a suitable measure of airway inflammation and its application may reinforce the power of epidemiological surveys on respiratory health.
Authors: J G van Amsterdam; A P Verlaan; H van Loveren; S G Vos; A Opperhuizen; P A Steerenberg Journal: Int Arch Occup Environ Health Date: 1999-09 Impact factor: 3.015
Authors: J G van Amsterdam; A Hollander; J D Snelder; P H Fischer; H van Loveren; J G Vos; A Opperhuizen; P A Steerenberg Journal: Nitric Oxide Date: 1999-12 Impact factor: 4.427
Authors: P A Steerenberg; J B Snelder; P H Fischer; J G Vos; H van Loveren; J G van Amsterdam Journal: Eur Respir J Date: 1999-02 Impact factor: 16.671
Authors: P H Fischer; P A Steerenberg; J D Snelder; H van Loveren; J G C van Amsterdam Journal: Int Arch Occup Environ Health Date: 2002-03-19 Impact factor: 3.015
Authors: J C MacPherson; S A Comhair; S C Erzurum; D F Klein; M F Lipscomb; M S Kavuru; M K Samoszuk; S L Hazen Journal: J Immunol Date: 2001-05-01 Impact factor: 5.422
Authors: James L Puckett; Richard W E Taylor; Szu-Yun Leu; Olga L Guijon; Anna S Aledia; Stanley P Galant; Steven C George Journal: Respir Res Date: 2010-04-28
Authors: Robert S Tepper; Conrado J Llapur; Marcus H Jones; Christina Tiller; Cathy Coates; Risa Kimmel; Jeffrey Kisling; Barry Katz; Yan Ding; Nancy Swigonski Journal: J Allergy Clin Immunol Date: 2008-08-28 Impact factor: 10.793
Authors: Daniel J Jackson; Christine M Virnig; Ronald E Gangnon; Michael D Evans; Kathy A Roberg; Elizabeth L Anderson; Ryan M Burton; Lisa P Salazar; Douglas F DaSilva; Kathleen M Shanovich; Christopher J Tisler; James E Gern; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2009-09-12 Impact factor: 10.793